Qiagen reports sales increases for Q2
Qiagen announced sales increases in its financial report for the second quarter of 2021. Read More
Stilla launches 6-color digital PCR system
Stilla Technologies has launched its six-color Crystal Digital PCR access program, which provides the industry with early access to its digital polymerase chain reaction (PCR) system featuring six fluorescent channels. Read More
Deep Genomics gets $180M for programmable RNA therapies
Deep Genomics has closed $180 million in series C financing to expand its artificial intelligence platform for programmable RNA therapeutics and to support the advancement of its candidates into the clinic. Read More
Ring Therapeutics nabs $117M for vector platform for gene therapy
Ring Therapeutics has raised $117 million to support the continued development and expansion of its novel vector Anellogy platform. Read More
Sartorius buys viral vector media company Xell for $59M
Sartorius Stedim Biotech has acquired cell culture company Xell, which is headquartered in Bielefeld, Germany. Read More
BostonGene touts prostate cancer research results
Biomedical software firm BostonGene is highlighting research published in Clinical Cancer Research that identified particular molecular, cellular, and structural characteristics associated with magnetic resonance imaging-visible, clinically significant prostate cancer. Read More
Thermo Fisher reports high revenues in Q2
Thermo Fisher Scientific reported a significant revenue increase during the second quarter of 2021. Read More
Eurekare introduces awards to support synthetic biology
Eurekare has launched Eurekawards, a competition aimed at discovering and supporting ambitious synthetic biology projects from across Europe. Read More
Bio-Techne, Progen launch Simple Plex AAV2 immunoassay
Bio-Techne and Progen have launched the Simple Plex adeno-associated virus 2 (AAV2) viral titer assay for AAV2 total capsid quantification. Read More
Resilience to acquire Bluebird facility, partner on vector manufacturing
Bluebird Bio and National Resilience have formed a strategic alliance to accelerate the early research, development, and delivery of next-generation cell therapies. Read More
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Connect
